These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3511938)

  • 21. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ; Weinstein R; Rene P
    Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of mycoplasmas on phagocytosis and immunocompetence in rats.
    Thomsen AC; Heron I
    Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):67-71. PubMed ID: 373384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Humoral and cellular factors of immunological defense against infection exemplified by estrogen-facilitated pyelonephritis in rats].
    Freiesleben H; Sack K; Woermann K; Henkel W
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):314-20. PubMed ID: 4154603
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunological defense and virulence of the agent in experimental chronic infection].
    Henkel W; Freiesleben H; Wöhrmann W; Krüger C; Commichau R
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):306-13. PubMed ID: 4154602
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum resistance of Escherichia coli in chronic pyelonephritis. 1. Serum resistance in the human serum pool].
    Falkenhagen U; Handschuck I; Ulisko IN; Ratiner YuA ; Nimmich W; Zingler G; Naumann G
    Z Urol Nephrol; 1984 Jul; 77(7):391-400. PubMed ID: 6385542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical significance of immunological indices in chronic pyelonephritis].
    Shulutko BI; Kulaeva NN; Ambrozas IV; Shumilkin VR; Anikonova LI
    Ter Arkh; 1993; 65(6):11-3. PubMed ID: 8378837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohistochemical, immunocytochemical and electron microscope studies in experimental E. coli pyelonephritis].
    Iványi B; Krenács T
    Morphol Igazsagugyi Orv Sz; 1989 Apr; 29(2):98-105. PubMed ID: 2664479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyelonephritis: the role of cell-mediated immunity defined in a congenitally athymic rat.
    Miller T
    Kidney Int; 1984 Dec; 26(6):816-22. PubMed ID: 6398381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The etiological factors in pyelonephritis occurring against a background of nephrolithiasis].
    Savitskaia KI; Trapeznikova MF; Rusanova EV; Nekhorosheva AG; Solodilova OE
    Urol Nefrol (Mosk); 1995; (4):4-8. PubMed ID: 7571202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Incidence of antibody-coated bacteria in patients with chronic pyelonephritis].
    Falkenhagen U; Hacker K; Rehbock A; Handschuck I; Nimmich W
    Z Urol Nephrol; 1986 Nov; 79(11):609-18. PubMed ID: 3551385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of an autoimmune mechanism in pyelonephritis.
    Losse H; Intorp HW; Lison AE; Funke C
    Kidney Int Suppl; 1975 Aug; 4():S44-9. PubMed ID: 53317
    [No Abstract]   [Full Text] [Related]  

  • 32. Virulence of Escherichia coli strains in relation to their hemolysin formation, mannose-resistant hemagglutination, hydroxamate production, K 1-antigen and the plasmid profile in patients with chronic pyelonephritis.
    Fünfstück R; Tschäpe H; Stein G; Vollandt R; Schneider S
    Clin Nephrol; 1989 Oct; 32(4):178-84. PubMed ID: 2680194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunobiological study of colibacterial pyelonephritis].
    Podoplelov II; Samoĭlenko AS; Iudina II; Bakanova DIa; Burtsev VI
    Urol Nefrol (Mosk); 1974; (2):3-5. PubMed ID: 4141146
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of indirect hemagglutination test with polyvalent E. coli O antigens to diagnosis of pyelonephritis (author's transl)].
    Strohm WD; Osten O; Schoeppe B; Schoeppe W
    Med Klin; 1976 Aug; 71(35):1372-6. PubMed ID: 785184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term study of humoral immune response in patients with chronic pyelonephritis.
    Nimmich W; Budde E; Naumann G; Klinkmann H
    Clin Nephrol; 1976 Oct; 6(4):428-32. PubMed ID: 788977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of cyclophosphamide in experimental pyelonephritis in mice].
    Slavcheva E; Ivanova E; Georgiev D
    Eksp Med Morfol; 1984; 23(4):186-95. PubMed ID: 6396063
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression.
    Ahlstedt S
    Scand J Infect Dis Suppl; 1980; Suppl 24():216-9. PubMed ID: 7010558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunoglobulins in the serum of chronic pyelonephritis patients].
    Gruev I; Kiperova B; Mavromatis T; Altŭnkova I; Bocheva S
    Vutr Boles; 1986; 25(1):21-8. PubMed ID: 3087065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemiluminescence response of phagocytes in E. coli induced experimental ascending pyelonephritis.
    Gupta A; Kaur A; Majumdar S; Sharma BK; Ganguly NK
    Biochem Int; 1992 Feb; 26(1):43-50. PubMed ID: 1616496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis.
    Kaboré AF; Simard M; Bergeron MG
    J Infect Dis; 1999 May; 179(5):1162-72. PubMed ID: 10191219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.